Skip to main content
Top
Published in: Drugs & Aging 2/2009

01-02-2009 | Original Research Article

How Do Different Age Groups Use Benzodiazepines and Antidepressants?

Analysis of an Australian Administrative Database, 2003–6

Authors: Alesha J. Smith, Sue E. Tett

Published in: Drugs & Aging | Issue 2/2009

Login to get access

Abstract

Background: The use of antidepressants and benzodiazepines is increasing in Australia and worldwide, and it is thought that some of the prescribing of these classes of drugs may be inappropriate. However, the demographic characteristics of the subgroups of the population responsible for this increase remain unexplored.
Objective: The aim of this study was to examine changes in the utilization of antidepressants and benzodiazepines between different age groups within Australia from 2003 to 2006.
Methods: The Australian Pharmaceutical Benefits Scheme administrative database was used to obtain dispensing data for all antidepressants and publicly subsidized benzodiazepines. Changes in utilization (amounts and patterns of use of different compounds) were compared between different age groups from 2003 to 2006. The WHO Anatomic Therapeutic Chemical/Defined Daily Dose system was used.
Results: Use of antidepressants increased from 2003 to 2006, and in each year increased with age, with those ≥65 years having the greatest use. Differences were seen in the antidepressant most utilized, with the elderly using more tricyclic antidepressants than those who are younger. The utilization of benzodiazepines decreased from 2003 to 2006 in elderly individuals and those receiving social welfare benefits. Individuals aged ≥85 years had the highest use of benzodiazepines and used more long-acting benzodiazepines compared with those aged 35–44 years.
Conclusion: The elderly still account for most use per capita of benzodiazepines. Some of this use may be inappropriate (e.g. use of long-acting benzodiazepines) and, hence, may represent a useful target for future educational intervention. The elderly also still account for the largest per capita use of antidepressants.
Literature
1.
go back to reference Argyropoulos SV, Nutt DJ. The use of benzodiazepines in anxiety and other disorders. Eur Neuropsychopharmacol 1999 Dec; 9Suppl. 6: S407–12PubMedCrossRef Argyropoulos SV, Nutt DJ. The use of benzodiazepines in anxiety and other disorders. Eur Neuropsychopharmacol 1999 Dec; 9Suppl. 6: S407–12PubMedCrossRef
3.
go back to reference Smith A, Sketris I, Cooke C, et al. A comparison of benzodiazepines and related drug use in Nova Scotia, Canada and Australia. Can J Psychiatry 2008; 53(8): 546–52 Smith A, Sketris I, Cooke C, et al. A comparison of benzodiazepines and related drug use in Nova Scotia, Canada and Australia. Can J Psychiatry 2008; 53(8): 546–52
4.
go back to reference Mant A, Rendle VA, Hall WD, et al. Making new choices about antidepressants in Australia: the long view 1975–2002. Med J Aust 2004 Oct 4; 181 (7 Suppl.): S21–4PubMed Mant A, Rendle VA, Hall WD, et al. Making new choices about antidepressants in Australia: the long view 1975–2002. Med J Aust 2004 Oct 4; 181 (7 Suppl.): S21–4PubMed
5.
go back to reference Buffett-Jerrott SE, Stewart SH. Cognitive and sedative effects of benzodiazepine use. Curr Pharm Des 2002; 8(1): 45–58PubMedCrossRef Buffett-Jerrott SE, Stewart SH. Cognitive and sedative effects of benzodiazepine use. Curr Pharm Des 2002; 8(1): 45–58PubMedCrossRef
6.
go back to reference French DD, Campbell R, Spehar A, et al. Benzodiazepines and injury: a risk adjusted model. Pharmacoepidemiol Drug Saf 2005 Jan; 14(1): 17–24PubMedCrossRef French DD, Campbell R, Spehar A, et al. Benzodiazepines and injury: a risk adjusted model. Pharmacoepidemiol Drug Saf 2005 Jan; 14(1): 17–24PubMedCrossRef
7.
go back to reference Aparasu R, Mort J. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 2000; 34(3): 338–46PubMedCrossRef Aparasu R, Mort J. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 2000; 34(3): 338–46PubMedCrossRef
8.
go back to reference Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997 Jul 28; 157(14): 1531–6PubMedCrossRef Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997 Jul 28; 157(14): 1531–6PubMedCrossRef
9.
go back to reference Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003 Dec 8–22; 163(22): 2716–24PubMedCrossRef Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003 Dec 8–22; 163(22): 2716–24PubMedCrossRef
10.
go back to reference Alonso J, Angermeyer MC, Bernert S, et al. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004; 109(420): 55–64CrossRef Alonso J, Angermeyer MC, Bernert S, et al. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004; 109(420): 55–64CrossRef
11.
go back to reference MaGPIe Research Group. The treatment of common mental health problems in general practice. Fam Pract 2006; 23: 53–9CrossRef MaGPIe Research Group. The treatment of common mental health problems in general practice. Fam Pract 2006; 23: 53–9CrossRef
12.
go back to reference Simon GE, Fleck M, Lucas R, et al. Prevalence and predictors of depression treatment in an international primary care study. Am J Psychiatry 2004 Sep; 161(9): 1626–34PubMedCrossRef Simon GE, Fleck M, Lucas R, et al. Prevalence and predictors of depression treatment in an international primary care study. Am J Psychiatry 2004 Sep; 161(9): 1626–34PubMedCrossRef
13.
go back to reference Lambert MF, Masters GA, Brent SL. Can mass media campaigns change antimicrobial prescribing? A regional evaluation study. J Antimicrob Chemother 2007 Mar; 59(3): 537–43PubMedCrossRef Lambert MF, Masters GA, Brent SL. Can mass media campaigns change antimicrobial prescribing? A regional evaluation study. J Antimicrob Chemother 2007 Mar; 59(3): 537–43PubMedCrossRef
14.
go back to reference Randolph W, Viswanath K. Lessons Learned from public health mass media campaigns: marketing health in a crowded media world. Annu Rev Public Health 2004; 25: 419–37PubMedCrossRef Randolph W, Viswanath K. Lessons Learned from public health mass media campaigns: marketing health in a crowded media world. Annu Rev Public Health 2004; 25: 419–37PubMedCrossRef
19.
go back to reference Sketris I, Metge C, Ross J, et al. The use of the World Health Organisation Anatomical Therapeutic Chemical/Defined Daily Dose methodology in Canada. Drug Inf J 2004; 38(1): 15–27CrossRef Sketris I, Metge C, Ross J, et al. The use of the World Health Organisation Anatomical Therapeutic Chemical/Defined Daily Dose methodology in Canada. Drug Inf J 2004; 38(1): 15–27CrossRef
20.
go back to reference World Health Organisation. WHO Collaborating Centre for Drug Statistics Methodology, guidelines for ATC classification and DDD assignment 2006. 9th ed. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2005 World Health Organisation. WHO Collaborating Centre for Drug Statistics Methodology, guidelines for ATC classification and DDD assignment 2006. 9th ed. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2005
21.
go back to reference Bergman U, Popa C, Tomson Y, et al. Drug utilization 90%: a simple method for assessing the quality of drug prescribing. Eur J Clin Pharmacol 1998 Apr; 54(2): 113–8PubMedCrossRef Bergman U, Popa C, Tomson Y, et al. Drug utilization 90%: a simple method for assessing the quality of drug prescribing. Eur J Clin Pharmacol 1998 Apr; 54(2): 113–8PubMedCrossRef
22.
go back to reference Bambauer KZ, Adams AS, Zhang F, et al. Physician alerts to increase antidepressant adherence: fax or fiction? Arch Intern Med 2006 Mar 13; 166(5): 498–504PubMedCrossRef Bambauer KZ, Adams AS, Zhang F, et al. Physician alerts to increase antidepressant adherence: fax or fiction? Arch Intern Med 2006 Mar 13; 166(5): 498–504PubMedCrossRef
23.
go back to reference Dollman WB, Leblanc VT, Stevens L, et al. Achieving a sustained reduction in benzodiazepine use through implementation of an area-wide multi-strategic approach. J Clin Pharm Ther 2005 Oct; 30(5): 425–32PubMedCrossRef Dollman WB, Leblanc VT, Stevens L, et al. Achieving a sustained reduction in benzodiazepine use through implementation of an area-wide multi-strategic approach. J Clin Pharm Ther 2005 Oct; 30(5): 425–32PubMedCrossRef
24.
26.
go back to reference Richards JC, Ryan P, McCabe MP, et al. Barriers to the effective management of depression in general practice. Aust N Z J Psychiatry 2004 Oct; 38(10): 795–803PubMedCrossRef Richards JC, Ryan P, McCabe MP, et al. Barriers to the effective management of depression in general practice. Aust N Z J Psychiatry 2004 Oct; 38(10): 795–803PubMedCrossRef
27.
go back to reference Howard M, Dolovich L, Kaczorowski J, et al. Prescribing of potentially inappropriate medications to elderly people. Fam Pract 2004 Jun; 21(3): 244–7PubMedCrossRef Howard M, Dolovich L, Kaczorowski J, et al. Prescribing of potentially inappropriate medications to elderly people. Fam Pract 2004 Jun; 21(3): 244–7PubMedCrossRef
28.
go back to reference McGarry H, Hegarty K, Gunn J. How do Victorian GPs manage patients with depression? Aust Fam Physician 2005 Jul; 34(7): 603–6PubMed McGarry H, Hegarty K, Gunn J. How do Victorian GPs manage patients with depression? Aust Fam Physician 2005 Jul; 34(7): 603–6PubMed
29.
go back to reference Goldney RD, Fisher LJ, Grande ED, et al. Have education and publicity about depression made a difference? Comparison of prevalence, service use and excess costs in South Australia: 1998 and 2004. Aust N Z J Psychiatry 2007 Jan; 41(1): 38–53PubMedCrossRef Goldney RD, Fisher LJ, Grande ED, et al. Have education and publicity about depression made a difference? Comparison of prevalence, service use and excess costs in South Australia: 1998 and 2004. Aust N Z J Psychiatry 2007 Jan; 41(1): 38–53PubMedCrossRef
30.
go back to reference Sihvo S, Isometsa E, Kiviruusu O, et al. Antidepressant utilisation patterns and determinants of short-term and non-psychiatric use in the Finnish general adult population. J Affect Disord 2008 Sep; 110(1–2): 94–105PubMedCrossRef Sihvo S, Isometsa E, Kiviruusu O, et al. Antidepressant utilisation patterns and determinants of short-term and non-psychiatric use in the Finnish general adult population. J Affect Disord 2008 Sep; 110(1–2): 94–105PubMedCrossRef
31.
go back to reference Hollingworth S, Nissen L. Use of tricyclic antidepressants in Australia. University of Queensland, 2008. (Data on file) Hollingworth S, Nissen L. Use of tricyclic antidepressants in Australia. University of Queensland, 2008. (Data on file)
32.
go back to reference Anstey KJ, von Sanden C, Sargent-Cox K, et al. Prevalence and risk factors for depression in a longitudinal, population-based study including individuals in the community and residential care. Am J Geriatr Psychiatry 2007 Jun 1; 15(6): 497–505PubMedCrossRef Anstey KJ, von Sanden C, Sargent-Cox K, et al. Prevalence and risk factors for depression in a longitudinal, population-based study including individuals in the community and residential care. Am J Geriatr Psychiatry 2007 Jun 1; 15(6): 497–505PubMedCrossRef
33.
go back to reference Smith AJ, Sketris I, Cooke C, et al. A comparison of antidepressant use in Nova Scotia, Canada and Australia. Pharmacoepidemiol Drug Saf 2008 Jul; 17(7): 697–706PubMedCrossRef Smith AJ, Sketris I, Cooke C, et al. A comparison of antidepressant use in Nova Scotia, Canada and Australia. Pharmacoepidemiol Drug Saf 2008 Jul; 17(7): 697–706PubMedCrossRef
34.
go back to reference Mant A, Whicker SD, McManus P, et al. Benzodiazepine utilisation in Australia: report from a new pharmacoepidemiological database. Aust J Public Health 1993 Dec; 17(4): 345–9PubMedCrossRef Mant A, Whicker SD, McManus P, et al. Benzodiazepine utilisation in Australia: report from a new pharmacoepidemiological database. Aust J Public Health 1993 Dec; 17(4): 345–9PubMedCrossRef
35.
go back to reference Mant A, McManus P. Benzodiazepine use: continuing to fall [letter]. Med J Aust 1994 Oct 3; 161(7): 454PubMed Mant A, McManus P. Benzodiazepine use: continuing to fall [letter]. Med J Aust 1994 Oct 3; 161(7): 454PubMed
36.
go back to reference Voyer P, Verreault R, Mengue PN, et al. Prevalence of insomnia and its associated factors in elderly long-term care residents. Arch Gerontol Geriatr 2006; 42(1): 1–20PubMedCrossRef Voyer P, Verreault R, Mengue PN, et al. Prevalence of insomnia and its associated factors in elderly long-term care residents. Arch Gerontol Geriatr 2006; 42(1): 1–20PubMedCrossRef
37.
go back to reference Ohayon MM, Caulet M, Priest RG, et al. Psychotropic medication consumption patterns in the UK general population. J Clin Epidemiol 1998; 51(3): 273–83PubMedCrossRef Ohayon MM, Caulet M, Priest RG, et al. Psychotropic medication consumption patterns in the UK general population. J Clin Epidemiol 1998; 51(3): 273–83PubMedCrossRef
38.
go back to reference Rojas-Fernandez CH, Carver D, Tonks R. Population trends in the prevalence of benzodiazepine use in the older population of Nova Scotia: a cause for concern? Can J Clin Pharmacol 1999 Autumn; 6(3): 149–56PubMed Rojas-Fernandez CH, Carver D, Tonks R. Population trends in the prevalence of benzodiazepine use in the older population of Nova Scotia: a cause for concern? Can J Clin Pharmacol 1999 Autumn; 6(3): 149–56PubMed
39.
go back to reference Pariente A, Dartigues JF, Benichou J, et al. Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging 2008; 25(1): 61–70PubMedCrossRef Pariente A, Dartigues JF, Benichou J, et al. Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging 2008; 25(1): 61–70PubMedCrossRef
Metadata
Title
How Do Different Age Groups Use Benzodiazepines and Antidepressants?
Analysis of an Australian Administrative Database, 2003–6
Authors
Alesha J. Smith
Sue E. Tett
Publication date
01-02-2009
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 2/2009
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/0002512-200926020-00003

Other articles of this Issue 2/2009

Drugs & Aging 2/2009 Go to the issue

Adis Drug Evaluation

Bimatoprost/Timolol